Related Experiment Video
Updated: Aug 10, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Mu-opioid receptors are involved in the tolerance to nicotine antinociception
Lola Galeote1, Brigitte L Kieffer, Rafael Maldonado
1Laboratori de Neurofarmacologia, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain. rafael.maldonado@upf.edu
Abstract:
Several studies have shown the participation of the endogenous opioid system on the antinociceptive effects and addictive properties of nicotine. The aim of the present study was to explore the involvement of the mu-opioid receptors in the development of tolerance to nicotine antinociception. Chronic treatment of C57BL/6 mice with nicotine (5 mg/kg s.c., three times daily during 12 days) resulted in tolerance to its antinociceptive responses in the tail-immersion test. We investigated the possible existence of adaptive changes in the expression and/or functional activity of mu-opioid receptors in these tolerant mice by using autoradiography of [(3)H]D-Ala(2)-MePhe(4)-Gly-ol(5) enkephalin ([(3)H]DAMGO) binding and DAMGO-stimulated guanosine [(35)S]5'-(gamma-thio)-triphosphate ([(35)S]GTPgammaS) binding. The density of mu-opioid receptors in the spinal cord was not modified in nicotine-tolerant mice, whereas a decrease was found in the caudate-putamen, as well as in the core and the shell of the nucleus accumbens. However, the functional activity of these receptors was significantly increased in the spinal cord as a consequence of nicotine treatment. To further investigate the role of mu-opioid receptors in the tolerance to nicotine-induced antinociception, we evaluated this response in C57BL/6 mu-opioid receptor knockout mice. Chronic nicotine treatment produced tolerance in both wild-type and knockout animals, but tolerance developed faster in mice lacking mu-opioid receptors. These results indicate that mu-opioid receptors play an important role in the development of tolerance to nicotine antinociceptive effects.
Insights
Mu-opioid receptors are involved in nicotine tolerance. While their density changed in some brain areas, their spinal cord activity increased, suggesting a complex role in developing tolerance to nicotine
Area of Science:
- Neuroscience
- Pharmacology
Background:
- The endogenous opioid system influences nicotine's effects on pain and addiction.
- Understanding the role of specific opioid receptors, like mu-opioid receptors, is crucial for elucidating nicotine's mechanisms of action.
Purpose of the Study:
- To investigate the involvement of mu-opioid receptors in the development of tolerance to nicotine's antinociceptive effects.
- To explore adaptive changes in mu-opioid receptor expression and function following chronic nicotine exposure.
Main Methods:
- Chronic nicotine administration to C57BL/6 mice to induce tolerance.
- Autoradiography using [(3)H]DAMGO to assess mu-opioid receptor density.
- Guanosine [(35)S]5'-(gamma-thio)-triphosphate ([(35)S]GTPgammaS) binding assays to measure receptor functional activity.
- Evaluation of nicotine-induced antinociception in mu-opioid receptor knockout mice.
Main Results:
- Chronic nicotine treatment led to tolerance in the tail-immersion test.
- Mu-opioid receptor density decreased in the caudate-putamen and nucleus accumbens but remained unchanged in the spinal cord.
- Functional activity of spinal mu-opioid receptors significantly increased after nicotine treatment.
- Tolerance to nicotine's antinociceptive effects developed faster in mu-opioid receptor knockout mice compared to wild-type.
Conclusions:
- Mu-opioid receptors play a significant role in the development of tolerance to nicotine's antinociceptive effects.
- Adaptive changes in mu-opioid receptor function, particularly in the spinal cord, contribute to nicotine tolerance.
- The absence of mu-opioid receptors accelerates the development of nicotine tolerance, highlighting their modulatory role.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Opioid Analgesics: Morphine and Other Natural Cogeners
CNS Depressants: Alcohol and Nicotine

